Covid-19 non-invasive rapid detection system, prototype screening devices to be used for data gathering purposes in order to evaluate the effectiveness of the technology.
Ended Definitive Contract Awarded Last action
- Contract number
- W911SR21C0008
- Awardee
-
Worlds Enterprises Inc. UEI HANBK48KT8C7
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $392,500
Award facts
- Opportunity
-
- Needles and Syringes Solicitation · Posted May 26, 2020
- Non-Invasive Rapid Detection System (NIRDS) Phase 1 Award Notice · Posted Feb 8, 2021
- Contract value 100% obligated
- $392,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- 1701 Kenly Ave #134, Lackland AFB, TX 78236, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | -$9,850 | |
| Change Order | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Original award | $402,350 |
About this award
This $392,500 firm fixed price contract was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Worlds Enterprises Inc. to supply prototype COVID-19 non-invasive rapid detection system screening devices. The devices will be used by the Army to gather data and evaluate the effectiveness of the technology in responding to the coronavirus pandemic. Performance will take place in Lackland Air Force Base, Texas from November 2020 through July 2021. The original solicitation sought proposals for up to 500 million FDA-approved combination needle and syringe units or individual sterile needles and syringes to supply the Department of Health and Human Services' Assistant Secretary for Preparedness and Response and Biomedical Advanced Research and Development Authority in response to COVID-19, with no set-aside designation.
Quick answers
Who was awarded contract W911SR21C0008?
W911SR21C0008 was awarded to Worlds Enterprises Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on November 13, 2020.
How much is contract W911SR21C0008 worth?
The government has obligated $392,500 on W911SR21C0008.
Which agency awarded contract W911SR21C0008?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR21C0008, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911SR21C0008 competed?
The extent of competition for W911SR21C0008 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award